Skip to content

A double-blind randomized controlled trial in the study of the effectiveness of Parent-Child interaction therapy on anxiety and cortisol level in preschool children with parents who use Gul

A double-blind randomized controlled trial in the study of the effectiveness of Parent-Child interaction therapy on anxiety and cortisol level in preschool children with parents who use Gul

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180414004
Enrollment
64
Registered
2018-04-14
Start date
2015-03-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration. Parent&#45

Interventions

Child Interaction Therapy (PCIT) is evidence&#45
term and based on interest and social learning theory that is used in children aged between two and eight years with a history of disruptive behavior disorders. ,In the placebo group&#44
and the process of data analysis was carried out by a psychometric analyzer.
Child Interaction Therapy (PCIT),placebo group (a combination of motivational interviewing and cognitive&#45
behavioral therapy )

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 7 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were: 1) age range of 5-7 years in children; 2) the diagnosis of dependence to Gol with a given dose for at least one of the parents; 3) the diagnosis of anxiety disorder in the child based on DSM- TR; 4) age range of 20 -45 years for parents; and 5) the ability to read and write.

Exclusion criteria

Exclusion criteria: The exclusion criteria for mothers and children were as follow: 1) lack of natural intelligence with a criterion of less than 70; 2) use of more than three months from psychiatric medications due to the possible effect on the psychological syndrome.

Design outcomes

Primary

MeasureTime frame
children's anxiety 12 weeks Spence Children's Anxiety Scale (SCAS)

Secondary

MeasureTime frame
salivary cortisol 12 weeks enzyme-linked immunosorbent assay (ELISA)

Countries

iran

Contacts

Public Contactbijan pirnia

Bijan Center

b.pirnia@usc.ac.ir+9802122081450

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026